Scientia Advisors, a management consulting firm specializing in the life sciences industry, has appointed Patrick Terry to lead its pricing and reimbursement/market access practice.
Terry co-founded Genomic Health, the Personalized Medicine Coalition, the European Personalized Medicine Association, and the Coalition for 21st Century Medicine.
At Scientia, Terry will manage a practice focused on helping drug, diagnostics, and medical device firms in North America and Europe develop and implement reimbursement and pricing strategies.
"In my new role at Scientia, I will bring together and manage the integration of multidisciplinary team of experts — researchers, analysts, health economists, technical reimbursement staff, and payer engagement folks — to focus on market access for an array of life science products," Terry told PGx Reporter.
The services provided under Terry's leadership will include health technology assessment, clinical and cost comparative effectiveness, pricing and market value positioning, reimbursement services, payor and evidence dossiers, and pricing alignment and global commercialization strategies.
"Certainly my experience points toward the personalized medicine field, but we cast a much wider net to work on the whole array of commercial challenges facing medical innovation generally, as well as products such as information-based products, regenerative medicine, advanced combination products, and new fields of medicine," Terry added.
Oncology diagnostics firm On-Q-ity named Walter Carney as its new chief scientific officer. Carney comes to On-Q-ity from Oncogene Science, where he was chief executive officer. He also currently serves as assistant clinical professor at the department of pathology at the Tufts Medical Center.